Fig. 1From: Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancerThe decision tree and partitioned survival model structure overview for advanced NSCLC patients. Abbreviations: PartSA, partitioned survival approach; NSCLC, non-small cell lung cancerBack to article page